| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,163,251 |
|
|
| Direct
Value |
$177,622,952 |
|
|
|
Indirect Value
|
$145,172,275 |
|
|
| Total
Shares |
89,119,429 |
|
|
| Total
Value |
$322,795,227 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2024-01-26 |
1,912,156 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
635 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-19 |
4 |
S |
$1.76 |
$8,976 |
I/I |
(5,100) |
627,994 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-05 |
4 |
S |
$2.52 |
$16,894 |
I/I |
(6,696) |
632,517 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-16 |
4 |
S |
$1.82 |
$12,740 |
I/I |
(7,000) |
633,094 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-04 |
4 |
S |
$2.46 |
$12,551 |
I/I |
(5,103) |
639,213 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-15 |
4 |
S |
$1.88 |
$11,889 |
I/I |
(6,324) |
640,094 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-04 |
4 |
B |
$2.14 |
$64,197 |
I/I |
30,000 |
643,254 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-03 |
4 |
S |
$2.54 |
$6,389 |
I/I |
(2,520) |
644,316 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-11 |
4 |
B |
$10.77 |
$627,047 |
I/I |
58,220 |
646,126 |
2.1 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-14 |
4 |
S |
$1.89 |
$34,383 |
I/I |
(18,192) |
646,418 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-02 |
4 |
S |
$2.55 |
$901 |
I/I |
(353) |
646,836 |
0 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2010-06-14 |
4 |
B |
$11.25 |
$56,264 |
I/I |
5,000 |
651,126 |
2.1 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2016-06-08 |
4 |
B |
$14.07 |
$369,647 |
I/I |
26,272 |
661,994 |
2.25 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-13 |
4 |
S |
$1.75 |
$12,250 |
I/I |
(7,000) |
664,610 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-12 |
4 |
S |
$1.80 |
$7,726 |
I/I |
(4,292) |
671,610 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-09 |
4 |
S |
$1.88 |
$19,086 |
I/I |
(10,152) |
675,902 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-08 |
4 |
S |
$1.91 |
$10,123 |
I/I |
(5,300) |
686,054 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-05 |
4 |
B |
$2.05 |
$97,026 |
I/I |
47,293 |
690,547 |
1.5 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-07 |
4 |
S |
$1.91 |
$6,693 |
I/I |
(3,504) |
691,354 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-08 |
4 |
B |
$2.03 |
$4,262 |
I/I |
2,100 |
692,647 |
1.42 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-06 |
4 |
S |
$1.96 |
$13,720 |
I/I |
(7,000) |
694,858 |
0 |
% |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2015-09-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
15 |
697,198 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2015-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
36 |
697,213 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
39 |
697,249 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
62 |
697,288 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2014-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,028 |
697,350 |
0 |
- |
|
635 Records found
|
|
Page 5 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
